11119959 · Active · incorporated 8 years, 7 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Series B+
Amphista Therapeutics develops medicines for hard-to-treat diseases using targeted protein degradation approaches.
See the complete cap table with every shareholder, founder tags, dilution across 24 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.